Pharmacoepidemiology is an international, peer-reviewed, open access journal on high-quality epidemiological, clinical research across the fields of clinical pharmacology and epidemiology, published quarterly online by MDPI.
  • Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
  • Rapid Publication: first decisions in 15 days; acceptance to publication in 3 days (median values for MDPI journals in the first half of 2022).
  • Recognition of Reviewers: APC discount vouchers, optional signed peer review, and reviewer names published annually in the journal.
  • Pharmacoepidemiology is a companion journal of Pharmaceuticals.
Add your e-mail address to receive forthcoming issues of this journal:
Topic in JCM, Pharmaceuticals, Pharmacoepidemiology, Pharmacy, Vaccines, Healthcare
Mass Vaccination Campaigns: From Post-authorization Benefit-Risk Assessment to Public Health Impact Topic Editors: Giampiero Mazzaglia, Lorenzo Mantovani, Ippazio Cosimo Antonazzo
Deadline: 30 November 2023
Special Issue in Pharmacoepidemiology
Pharmacoepidemiology and Addiction Guest Editor: Matthew Ellis
Deadline: 31 December 2022
Special Issue in Pharmacoepidemiology
Feature Papers of Pharmacoepidemiology 2022 Guest Editor: Cristina Bosetti
Deadline: 31 January 2023
Special Issue in Pharmacoepidemiology
Drug Safety and Effectiveness in the Real World Guest Editors: Li-Ting Kao, Yu-Tien Chang, Ke-Ting Pan
Deadline: 28 February 2023
Back to TopTop